State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT03761108 Phase 1, Phase 2
Recruiting
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory M...
Condition
Multiple Myeloma
Enrollment
387 pts
Location
United States, Belgium, Germany
Sponsor
Regeneron Pharmaceuticals
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
NCT06957327 Phase 1, Phase 2
Recruiting
A Study of ERAS-601 in People With Chordoma
Condition
Chordoma
Enrollment
46 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06424327 N/A
Recruiting
A Registry for People With Lung Cancer
Condition
Lung Cancer
Enrollment
600 pts
Location
United States, Canada
Sponsor
Memorial Sloan Kettering Cance
NCT04347473 Phase 4
Recruiting
ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.
Condition
Psoriasis
Enrollment
25 pts
Location
United States
Sponsor
Psoriasis Treatment Center of
NCT06095583 Phase 3
Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consol...
Condition
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Enrollment
756 pts
Location
United States, Belgium, China
Sponsor
Shanghai Junshi Bioscience Co.
NCT05672524 Phase 2
Recruiting
A Study of Tucatinib and Trastuzumab in People With Rectal Cancer
Condition
Adenocarcinoma of the Rectum
Enrollment
37 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07124520 N/A
Recruiting
A Study of Tongue Strength and Endurance Using the Iowa Oral Performance Instrum...
Condition
Tongue Cancer
Enrollment
60 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT00539162 N/A
Recruiting
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Ris...
Condition
Ovarian Cancer
Enrollment
8,000 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
NCT06344559 N/A
Recruiting
Brain Criticality, Oculomotor Control, and Cognitive Effort
Condition
Healthy
Enrollment
60 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
NCT05910294 N/A
Recruiting
A Study to Prevent and Improve Sexual Health Concerns for People With Breast Can...
Condition
Improve Sexual Health
Enrollment
50 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT05332002 Phase 2
Recruiting
sFOLFOXIRI in Advanced Gastroesophageal Cancer, (SAGE)
Condition
Gastro-Intestinal Cancer
Enrollment
38 pts
Location
United States
Sponsor
Rutgers, The State University
NCT04468841 Phase 1
Recruiting
Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma
Condition
Follicular Lymphoma
Enrollment
100 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT03906617 Phase 4
Recruiting
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
Condition
Robotic Lung Surgery
Enrollment
34 pts
Location
United States
Sponsor
The Cooper Health System
NCT07356154 Phase 1, Phase 2
Recruiting
A Study of Revumenib and Mezigdomide in People With Leukemia
Condition
Leukemia
Enrollment
52 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07011862 N/A
Recruiting
COBRA: Cancer, Older Adults, Balance and Resistance Activities
Condition
Primary Cancer
Enrollment
38 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06795022 Phase 1, Phase 2
Recruiting
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metast...
Condition
Hepatocellular Carcinoma
Enrollment
304 pts
Location
United States, China, Hong Kong
Sponsor
AstraZeneca
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group